Digital Health in Pharma News
Shutterstock
Future Fields Announces New Paradigm in CDMO Services
Future Fields recently announced the launch of its contract development and manufacturing organisation (CDMO) service. Read more
21 Sep 2023
Shutterstock
Natural Cycles Receives FDA Clearance to Integrate Birth Control App with Apple Watch Data
Natural Cycles, the company that developed the world’s first birth control app, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its use of wrist temperature data from Apple Watch. Read more
19 Sep 2023
BenevolentAI Doses First Participants in Clinical Trial
BenevolentAI doses first participants in clinical trial of BEN-8744; targets PDE10, an AI-derived novel target for the treatment of Ulcerative Colitis. Read more
4 Sep 2023
Online Pharmacies Warned of the Impact of Upcoming Online Safety Bill
Online pharmacies selling age-restricted non-prescription drugs and medicines, are exploiting a current lack of regulation and face being unprepared for the online safety bill due this Autumn. Read more
24 Aug 2023
Hyfe AI and ActiGraph Partner to Revolutionise Clinical Trials with AI-Powered Cough Detection
Hyfe's technology integrated into ActiGraph’s new FDA-cleared LEAP wearable device that will advance the use of remote patient monitoring in chronic cough clinical research. Read more
16 Aug 2023
Cognizant expands generative AI partnership with Google Cloud
Cognizant will build on Google Cloud's generative AI technology to create healthcare large language model solutions, bringing the potential of generative AI to a range of healthcare business challenges. Read more
4 Aug 2023
Shutterstock
AI for Pharma Companies: The Role of Legal Departments
Jerry Temko, Managing Director, In-House Counsel Group, Major, Lindsey & Africa explores how Life science companies are becoming more alive to the role that in-house legal teams will play in safely and successfully taking on the AI challenge. Read more
22 Sep 2023
Future Pharma: How digital transformation will revolutionise our time-to-market
Developing new drugs is expensive and time-consuming, yet, digital manufacturing techniques are delivering significant benefits without compromising on quality, as Eric Flynn, Head of Pharmaceuticals and Life Sciences at Siemens GB&I explains. Read more
22 Jun 2023
Key driver identification: Minimising variability in biopharmaceutical production
Neelanjan Sengupta explores Key driver identification: Minimising variability in biopharmaceutical production in our latest issue of EPM. Read more
21 Jun 2023
Shutterstock
Otsuka and Astex Announce the European Commission has Approved INAQOVI
Otsuka Pharmaceutical Europe Ltd. and Astex Pharmaceuticals, Inc. have announce that the European Commission (EC) has approved INAQOVI. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
Daiichi and AstraZeneca Breast Cancer Drug Hits Goal
Positive high-level results from the TROPION-Breast01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant and clinically meaningful improvement. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
Samsung Biologics Announce Agreement with Bristol Myers Squibb to Manufacture an Antibody Cancer Drug Substance
Samsung Biologics announced today a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
TurboFil Expands Development and Demonstration Facility
TurboFil Packaging Machines LLC has substantially expanded the product development and demonstration space at its Mount Vernon, NY headquarters. Read more
22 Sep 2023
Shutterstock
Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment
A partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive disorder. Read more
22 Sep 2023
Shutterstock
2San Partners With Phoenix Healthcare To Launch Self Diagnostic Tests In UK
2San is partnering with Phoenix Healthcare to allow independent pharmacies to stock an increased range of rapid self-diagnostic products. Read more
21 Sep 2023
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Wickham Micro Ltd
Pharmaceutical & Medical Device – Consultancy, Testing & Research Services Read more
